Development and validation of an antidrug antibody assay for TRK-950 using Melon™ gel and SPEAD pretreatment

The combination of pretreatment with Melon™ gel and SPEAD is applicable for clinical ADA assays.

Authors

Institutions

Publication Details

Journal
Bioanalysis
Published
2025-04-17
DOI
https://doi.org/10.1080/17576180.2025.2493607
Primary Topic
Biosimilars and Bioanalytical Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and validation of an antidrug antibody assay for TRK-950 using Melon™ gel and SPEAD pretreatment

Reiji Nishio, Keita Nakanaga, Akira Kurihara, Fumiyoshi Okano et al.
Bioanalysis
Biosimilars and Bioanalytical Methods
article

Development and validation of an antidrug antibody assay for TRK-950 using Melon™ gel and SPEAD pretreatment

Reiji Nishio, Keita Nakanaga, Akira Kurihara, Fumiyoshi Okano, Ryosuke Yoshinaga
article en

Abstract

The combination of pretreatment with Melon™ gel and SPEAD is applicable for clinical ADA assays.

BioanalysisVol. 17(8)
Toray (United States) (US)
Openalex Percentile: Top 91%
Biosimilars and Bioanalytical Methods
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development and validation of an antidrug antibody assay for TRK-950 using Melon™ gel and SPEAD pretreatment — Reiji Nishio, Keita Nakanaga, et al. · Bioanalysis (2025) | TGRS Research Map | TGRS